Summit Therapeutics (SMMT) Earnings Date, Estimates & Call Transcripts $28.66 +0.59 (+2.10%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$28.65 -0.01 (-0.03%) As of 08/8/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Summit Therapeutics Earnings Summary Summit Therapeutics issued Q1 2025 earnings on May 1, 2025, reporting an EPS of -$0.09, which topped the consensus estimate of -$0.10 by $0.01. With a trailing EPS of -$0.34, Summit Therapeutics' earnings are expected to decrease next year, from ($0.30) to ($0.36) per share. Upcoming Q2 Earnings DateAug. 12Before Market OpensEstimatedConsensus EPS (May. 1) -$0.10 Actual EPS (May. 1) -$0.09 Beat By $0.01 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q) Slide DeckSEC FilingSMMT Upcoming EarningsSummit Therapeutics' Q2 2025 earnings is scheduled for Tuesday, August 12, 2025Slide DeckFull Screen Slide DeckPowered by Get Summit Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Summit Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSMMT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SMMT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Summit Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.09-$0.09-$0.09Q2 20252-$0.10-$0.09-$0.10Q3 20252-$0.10-$0.10-$0.10Q4 20252-$0.11-$0.10-$0.11 FY 2025 7 -$0.40 -$0.38 -$0.39 Q1 20261-$0.09-$0.09-$0.09Q2 20261-$0.09-$0.09-$0.09Q3 20261-$0.09-$0.09-$0.09Q4 20261-$0.09-$0.09-$0.09 Summit Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------5/1/2025Q1 2025-$0.10-$0.09+$0.01-$0.09--2/24/2025Q4 2024-$0.08-$0.08--$0.08-$0.20M10/30/2024Q3 2024-$0.06-$0.08 -$0.02-$0.08--8/6/2024Q2 2024-$0.06-$0.05+$0.01-$0.01--5/1/2024Q1 2024-$0.06-$0.05+$0.01-$0.04--2/20/2024Q4 2023--$0.05--$0.05-$0.20M11/7/2023Q3 2023--$0.03--$0.03-$0.27M Summit Therapeutics Earnings - Frequently Asked Questions When is Summit Therapeutics' earnings date? Summit Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on SMMT's earnings history. Did Summit Therapeutics beat their earnings estimates last quarter? In the previous quarter, Summit Therapeutics (NASDAQ:SMMT) reported ($0.09) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.10) by $0.01. Learn more on analysts' earnings estimate vs. SMMT's actual earnings. How can I listen to Summit Therapeutics' earnings conference call? The conference call for Summit Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Summit Therapeutics' conference call transcript? The conference call transcript for Summit Therapeutics' latest earnings report can be read online. Read Transcript How can I view Summit Therapeutics' earnings report? Summit Therapeutics' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Summit Therapeutics generate each year? Summit Therapeutics (NASDAQ:SMMT) has a recorded annual revenue of $700,000.00. How much profit does Summit Therapeutics generate each year? Summit Therapeutics (NASDAQ:SMMT) has a recorded net income of -$221.32 million. SMMT has generated -$0.34 earnings per share over the last four quarters. What is Summit Therapeutics' EPS forecast for next year? Summit Therapeutics' earnings are expected to decrease from ($0.30) per share to ($0.36) per share in the next year. More Earnings Resources from MarketBeat Related Companies Merck & Co., Inc. Earnings Results GSK Earnings Results Takeda Pharmaceutical Earnings Results argenex Earnings Results BeOne Medicines Earnings Results BioNTech Earnings Results Insmed Earnings Results Teva Pharmaceutical Industries Earnings Results Genmab A/S Earnings Results Dr. Reddy's Laboratories Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Airbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a Rally This page (NASDAQ:SMMT) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
